Richard Alan Cash | |
---|---|
Born | June 9, 1941 Milwaukee, Wisconsin, USA |
Residence | Cambridge, Massachusetts, USA |
Nationality | USA/American |
Fields |
global health, medicine in the developing world, population health, infectious diseases, Ethical Issues in Global Health Research, development of individual and institution-based research capacity in developing nations, institution/capacity building in resource-poor nations, impediments and opportunities for global surveillance for infectious diseases, new and reemerging infectious diseases, role of research in the development of policy and program implementation |
Institutions | Johns Hopkins, Johns Hopkins Hospital, BRAC University, SEATO, Pakistan-SEATO Cholera Research Laboratory (CRL), Harvard T.H. Chan School of Public Health, Harvard University |
Alma mater |
University of Wisconsin–Madison, BS (pre-med), 1963 |
Known for | Developing oral rehydration therapy (ORT), infectious diseases, ethics of health research in the developing world, public health education |
Notable awards | The Prince Mahidol Award Medal, from His Royal Highness the King of Thailand (2006) |
University of Wisconsin–Madison, BS (pre-med), 1963
New York University School of Medicine, MD (1966)
Richard Alan Cash, M.D., M.P.H. (born June 9, 1941) is an American global health researcher, public health physician, internist, and Prince Mahidol Award / Medal winner. He is a Senior Lecturer in International Health and Director of the Program on Ethical Issues in International Health in the Department of Global Health & Population of the Harvard T.H. Chan School of Public Health in Boston. Prior to joining HSPH full-time, he was a Senior Fellow at the Harvard Institute for International Development (previously HIID, now CID) and part-time at HSPH. He is gifted at figuring out how to show others how to do much with very little.
Cash began his international career over 40 years ago when he was assigned by NIAID of the NIH to the Pakistan-SEATO Cholera Research Laboratory (CRL) in Dhaka, East Pakistan (now the ICDDR,B in Dhaka, Bangladesh). While there, he and his colleagues developed and conducted the first clinical trials of oral rehydration therapy (ORT) in adult and pediatric cholera patients and patients with other infectious causes of diarrhea. This technology matches the volume of fluid losses from dehydration patients with the volume they consume so that the fluid replacement packets greatly reduce or completely replace IV therapy (particularly where it is not feasible or unavailable), which was then the only current treatment for cholera. Discoveries in ORT have been estimated to have saved over 50 million lives worldwide.World Health Organization (WHO) estimates are that at least 60 million children have been spared painful deaths because of ORT. They also conducted the first field trials of ORT, the first community-based trials of ORT, and the first use of amino acids (glycine) as an additional substrate. In the late 1970s, Cash worked with BRAC (presently the world's largest NGO in terms of programs and personnel) on their OTEP (Oral Therapy Extension Programme), which taught over 13 million mothers and caregivers how to prepare and use ORT in the home using the "pinch and scoop" method.